Bedinvetmab
id:
bedinvetmab-224-2819719
title:
Bedinvetmab
text:
Bedinvetmab, sold under the brand name Librela is a canine monoclonal antibody used for the control of pain associated with osteoarthritis in dogs. Librela is sponsored by Zoetis. The most common side effects include increased blood urea nitrogen, urinary tract infection, bacterial skin infection, skin irritation (dermatitis), rash (erythema) or pain at injection site, vomiting (emesis), and weight loss (anorexia). Bedinvetmab was approved for medical use in the European Union in November 2020,
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Bedinvetmab
date created:
2023-05-13T16:01:30Z
date modified:
2024-09-14T14:35:48Z
main entity:
{"identifier":"Q118501961","url":"https://www.wikidata.org/entity/Q118501961"}
image:
fields total:
13
integrity:
15